The in vitro haemostatic functions of fresh whole blood (FWB) are well preserved after cold storage. This study aimed to determine whether platelets derived from FWB and stored whole blood (SWB) contribute to clot formation in tissue injury after transfusion into coagulopathic rats with polytrauma/haemorrhage (T/H). The rats were resuscitated 1 h after trauma with FWB or SWB collected from green fluorescence protein (GFP) transgenic rats. After transfusion, a liver incision was made and the tissue was collected 10 min after injury to identify GFP + platelets by immunohistochemistry. In comparison to FWB, platelet aggregation to adenosine diphosphate and protease-activated receptor-4 was reduced by 35% and 20%, and clotting time was shortened by 25% in SWB. After transfusion, SWB led to a significant increase in platelet activation as measured by an elevation of CD62P and phosphatidylserine expression. The platelets from SWB were in a higher activation state, and showed higher clearance rate and formation of platelet-leucocyte aggregates than those from FWB after transfusion. Platelets from both FWB and SWB were equivalently incorporated into the clot at the incisional site, as determined by co-localization of CD61 and GFP. This study suggests that SWB contributes to haemostatic function and is an effective alternative resource to treat trauma patients.
Summary
The in vitro haemostatic functions of fresh whole blood (FWB) are well preserved after cold storage. This study aimed to determine whether platelets derived from FWB and stored whole blood (SWB) contribute to clot formation in tissue injury after transfusion into coagulopathic rats with polytrauma/haemorrhage (T/H). The rats were resuscitated 1 h after trauma with FWB or SWB collected from green fluorescence protein (GFP) transgenic rats. After transfusion, a liver incision was made and the tissue was collected 10 min after injury to identify GFP + platelets by immunohistochemistry. In comparison to FWB, platelet aggregation to adenosine diphosphate and protease-activated receptor-4 was reduced by 35% and 20%, and clotting time was shortened by 25% in SWB. After transfusion, SWB led to a significant increase in platelet activation as measured by an elevation of CD62P and phosphatidylserine expression. The platelets from SWB were in a higher activation state, and showed higher clearance rate and formation of platelet-leucocyte aggregates than those from FWB after transfusion. Platelets from both FWB and SWB were equivalently incorporated into the clot at the incisional site, as determined by co-localization of CD61 and GFP. This study suggests that SWB contributes to haemostatic function and is an effective alternative resource to treat trauma patients.
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Polytrauma and haemorrhage (T/H) is the leading cause of mortality in patients younger than 45 years old in both the United States and worldwide (Krug et al, 2000; Rhee et al, 2014) . Approximately one-third of patients suffering major trauma develop acute traumatic coagulopathy (ATC), which is associated with an increased morbidity and mortality rate (Brohi et al, 2003; Niles et al, 2008; Pidcoke et al, 2012) . Implementation of damage control resuscitation protocols that emphasizes haemostatic resuscitation and is considered the current best strategy for treating severe trauma and haemorrhagic shock. Observational studies have suggested that resuscitation with fresh whole blood (FWB) yields better outcomes compared to component blood therapy in the treatment of severe trauma with exsanguinating haemorrhage (Spinella et al, 2009; Jones & Frazier, 2014) . This better outcome may be due to component therapy containing lower coagulation factor activity, haematocrit, and platelet counts on a volume basis as compared to fresh whole blood (Spinella et al, 2009) . FWB therefore should be the preferred resuscitative product for patients with traumatic haemorrhagic shock over other blood product combinations and fluids (Butler et al, 2014) . However, acquiring fresh blood is logistically challenging. Cold storage of whole blood is an US Food and Drug Administration-approved alternative approach. Recent studies also have shown that transfusion with group O, low anti-A and anti-B titre cold-stored whole blood as a "universal" product is safe in trauma resuscitation (Yazer et al, 2016; Seheult et al, 2017) . We have recently shown in a rat model of ATC (Darlington et al, 2013) that resuscitation with either FWB or whole blood stored at 4°C for 7 days (SWB) shows identical correction in haemodynamic and metabolic function, and equivalent impact on platelet function measured by aggregometry (Chen et al, 2017) . This suggests that whole blood, fresh or stored, could be considered as a primary resuscitation fluid for trauma and haemorrhagic shock. One of the primary haemostatic components of blood is platelets, which account for 70-80% of clot strength (Darlington et al, 2013) . It has been well-documented that coldstored platelets are cleared faster than fresh platelets (Murphy & Gardner, 1969) , which has traditionally been a major concern regarding the use of cold-stored platelets for treatment of thrombocytopenia. However, cold storage preserves platelet in vitro haemostatic function, mitigating the platelet storage lesion as compared to room temperature storage (Reddoch et al, 2014; Bynum et al, 2016) . It also has been reported that haemostatic and platelet function are well preserved in human whole blood stored at 4°C up to 14 days (Pidcoke et al, 2013) . It is possible that the preservation of haemostatic function may offset the decrease in circulation time of cold stored platelets in establishing overall haemostasis in bleeding patients. However, it is relatively unknown whether platelets derived from cold-stored whole blood participate in clot formation following a large injury with active bleeding in the situation of established coagulopathy.
In the current study, ATC and platelet dysfunction were induced in rats by polytrauma and 40% haemorrhage (T/H), followed by transfusion of either FWB or SWB collected from green fluorescence protein (GFP) transgenic donor rats so that GFP platelets derived from FWB and SWB could be determined in both circulation and in the clot of injured tissue after transfusion. We therefore were able to determine how many platelets circulated after transfusion of fresh or cold stored blood, whether the platelets were active, and whether they participate in clot formation.
Methods
This study was approved by the Institutional Animal Care and Use Committee of the US Army Institute of Surgical Research. This study was conducted in compliance with the Animal Welfare Act, the implementing Animal Welfare Regulations, and the principles of the "Guide for the Care and Use of Laboratory Animals". All experiments were started between 08:00 and 09:00 hours in a room separate from home caging. All rats (Sprague-Dawley from Charles Rivers, www.criver.com) were male, and were group housed. The light/dark cycle was 12 h light/12 h dark. The rats ate Laboratory Rodent Diet 5001 (www.LabDiet.com). Food and water were given ad libitum.
Polytrauma with haemorrhage (T/H)
We used a well-developed model that has been previously described (Darlington et al, 2013; Wu et al, 2016; Chen et al, 2017) . Briefly, rats (350-400 g) were anesthetized with 1-2% isoflurane/100% oxygen through a nose cone and allowed to breathe spontaneously. Cannulation was applied at the left femoral artery and vein for monitoring arterial blood pressure and blood withdrawal/transfusion respectively. Polytrauma was performed within 15 min by laparotomy, followed by crush injury at liver lobes, small intestines and right leg skeletal muscle; and closed fracture of the right femur. The rats were then bled to a mean arterial pressure of 40 mmHg within 5 min and maintained at 40 mmHg by repeated blood draws during the next 30-40 min until reaching 40% of estimated blood volume, calculated as 7% of body weight. After the haemorrhage process, blood pressure and heart rate were allowed to freely compensate. All rats survived during and after T/H.
Study protocol
Eighteen rats were randomly assigned to four groups: Sham + FWB; Sham + SWB, T/H + FWB, and T/H + SWB (Sham: n = 4/group; T/H: n = 5/group). One hour after trauma, T/H rats were resuscitated with FWB or SWB (20% of blood volume or half of shed blood). GFP transgenic rats (Sprague Dawley, Rat Resource & Research Center, Columbia, MO) were used as donor rats. Whole blood was collected in citrate phosphate dextrose. FWB was transfused within one hour from collection. SWB was kept in mini-blood-bags and refrigerated at 4°C for 7 days. Both FWB and SWB were filtered using 200 lm transfusion sets, and kept at 37°C with a heating pad before transfusion. Sham rats had no trauma, but 20% of whole blood was removed and replaced by 20% of donor blood (either FWB or SWB) to maintain euvolaemia at one hour after cannulation. Blood transfusion was allowed 5 min to complete. Immediately after blood transfusion, a liver incision (at nontraumatized lobe) was made to create an injury that allows spontaneous clotting. A standardized liver incision was made by a Surgicutt adult template device (International Technidyne Corp., Edison, NJ). The incised liver sample was collected 10 min after injury for immunohistochemical staining of CD61 (platelets) and GFP antibodies.
Haemostasis and platelet function of FWB and SWB
FWB and SWB were collected and prepared from 10 normal rats as described above. Platelet function (response to adenosine diphosphate [ADP], collagen and protease-activated receptor 4 [PAR4]) and coagulation properties of the samples collected from FWB and SWB were measured by aggregometry (Multiplate 5.0 Analyser, Dynabyte Medical, Munich, Germany) and rotational thromboelastometry (ROTEM, Munich, Germany) respectively, following manufacturer's instructions. The percent differences in platelet aggregation (area under curve), clotting time and maximum clot firmness) were calculated for SWB versus FWB.
Immunohistochemistry
The liver tissue was immediately embedded in optimal cutting temperature compound (Tissue-Tek, Sakura Finetek USA, Torrance, CA) and frozen in pre-chilled 2-methylbutane (Sigma-Aldrich, St. Louis, MO) for cryosectioning at 5-lm thickness. The tissue section was fixed in 1% paraformaldehyde with acetone at À20°C for 5 min. Antibody against CD61 (integrin B3) was used to identify platelets. The slides were treated with mouse monoclonal antirat CD61 (BD Pharmingen, San Jose, CA), and chicken monoclonal anti-GFP (Abcam, Cambridge, MA), or isotype controls at 4°C overnight; followed by treatment with secondary Alexa 594 conjugated anti-mouse IgG (ThermoFisher Scientific, Grand Island, NY) and Alexa 488 conjugated anti-chicken IgG (Abcam, Cambridge, MA). The slides were then co-stained with 4 0 ,6-diamidino-2-phenylindole (ThermoFisher Scientific, Grand Island, NY) for nuclear staining. The slides were observed and analysed under inverted fluorescence microscopy (Zeiss, Oberkochen, Germany). Platelets were identified as positively stained by CD61 in the clot that formed from the incision in the liver. Co-localization of CD61-positive clusters with GFP-positive signal in the clot was used to define the participation of donor platelets in clot formation. CD61-positive cluster without GFP positive signal was defined as the native platelets within the clot.
Flow cytometry
Flow cytometry was performed on a BD FacsCanto System (BD Biosciences, San Jose, CA). Blood samples from FWB, SWB and recipient rats at the end of experiment (10 min after transfusion) were analysed by flow cytometry using CD42d, CD45 and CD62P antibodies (eBioscience, ThermoFisher Scientific, San Diego, CA, USA) for defining platelets, leucocytes and activated platelets respectively. Lactadherin (Haematologic Technologies, Inc., Essex Junction, VT, USA) was used to detect phosphatidylserine (PS). Platelet-leucocyte aggregates were defined as CD42d+/CD45+. The transfused and native platelets were differentiated by GFP signal. Forward and side scatter characteristics were used to identify the platelet population, and 100,000 platelet events per sample were recorded. Geometric mean fluorescence intensity (GMFI) and abundance (% positive) of GFP platelets were reported.
Statistical analysis
Student t test (comparing platelet counts and activity of donor blood in fresh and after storage) and Two-Way analysis of variance (ANOVA) (comparing platelet counts and activity of recipient rats at 0 and 10 min after transfusion of FWB and SWB; and comparing platelet activity of transfused platelets and native platelets in recipient rats at 0 and 10 min after transfusion of FWB and SWB) were performed. Tukey's method was used for Post-hoc analysis after ANOVA. All data are represented as mean AE standard error of mean. Significance was indicated at P < 0Á05.
Results
The effect of cold storage on platelet counts, platelet activation and leucocyte interaction
The intensity of GFP signal was equally expressed in platelets derived from FWB and SWB (Fig 1C) , although total platelet counts and GFP + platelet% were slightly reduced in SWB (Fig 1A, B) . Whole blood storage at 4°C for 7 days led to a significant increase in the number of platelets expressing CD62P and PS (Fig 1D, E) , but not in the percentage of platelet-leucocyte aggregates as compared to FWB (Fig 1F) .
The effect of cold storage on platelet aggregation and coagulation parameters after transfusion
Cold stored blood showed a 35% and 20% reduction in the ability of platelets to aggregate in response to ADP and PAR4 (Fig 2A) . There was a 5% increase in aggregation response to collagen in SWB as compared to FWB (Fig 2A) . SWB showed a 25% reduction in clotting time (measured by ROTEM) as compared to FWB (Fig 2B) . Cold storage had no effect on mean clot firmness.
Platelet count, platelet activation, after transfusion
After transfusion (at 0 or 10 min), there was no significant change in platelet counts between SWB and FWB in either the sham or T/H recipient rats (Fig 3A) . The percentage of circulating GFP + platelets and the absolute GFP + platelet counts were slightly less than half after transfusion with SWB as compared to FWB in both sham and T/H rats (Fig 3B,  C) . There was no significant change of both GFP + platelet percentage and GFP + platelet counts among either sham or T/H rats at 10 min after transfusion. SWB transfusion led to significantly greater circulatory levels of the percentage of activated platelets (CD62P + and PS + ) and platelet-leucocyte aggregates in both sham and T/H rats (Fig 3D, E, F) . Interestingly, after transfusion, CD62P% was 10 times higher in GFP + platelets from SWB as compared to GFP + platelets from FWB, but the CD62P% of native platelets (GFP À ) was only slightly increased after SWB transfusion as compared to FWB. This suggests that the impact of SWB on the activity of native platelet was minimal (Fig 4A, B) . Additionally, there was a significant decline of CD62P + platelet percentage in circulating GFP platelets in both sham and T/H rats at 10 min after transfusion (Fig 3E) .
Blood pressure and haemostasis after resuscitation
Resuscitation with both FWB and SWB restored mean arterial blood pressure to within 10% of baseline in rats with trauma and haemorrhagic shock (Table I) . Also, no active bleeding from sites of prior injury and liver incision was observed at the end of experiment despite restoration of near normal blood pressure.
Donor platelets participate in clot formation
3GFP whole blood was transfused into both sham and T/H recipients to determine whether donor platelets participate in clot formation. We found that GFP platelets in whole blood from either FWB or SWB were abundantly incorporated into clots after lancing the liver (Fig 5) . Observation revealed clinically similar haemostasis in both transfusion groups, with no evidence of oozing or otherwise compromised function. The abundance of GFP-labelled platelets (derived from SWB or FWB) was similar in both sham and T/H recipients, even though T/H recipients were coagulopathic and had dysfunctional platelets (Darlington et al, 2013) . These data suggest that platelets from donors are incorporated into clots of recipient rats, and that platelets derived from either SWB or FWB beneficially support haemostasis after major injury.
Discussion
Current clinical guidelines for platelet transfusion have been mainly applicable to treatment of hypoproliferative thrombocytopenia with a primary goal of maintaining circulatory platelet numbers, but not platelet haemostatic function as a priority. In trauma, there is a greater immediate need for functional platelets, especially during active bleeding in a coagulopathic state. Therefore, monitoring the efficacy of platelet transfusion by relying on the number of circulating platelets post-transfusion may not be suitable for trauma patients. It is essential that platelets are functional and participate in clot formation after a traumatic event. We have now shown in a rat model that platelets from donors clearly participate in clot formation in either normal or coagulopathic rats. This suggests that the platelets in FWB or SWB can be expected to contribute to haemostasis after trauma even if the patient is coagulopathic and native platelets are dysfunctional.
Early studies in normal subjects have already documented that platelet concentrates stored at 4°C are cleared from circulation faster than fresh collected platelets or platelets stored at room temperature (Murphy & Gardner, 1969) , which has since been mechanistically described (Hoffmeister et al, 2003) . Our study suggests that trauma with haemorrhagic shock neither enhances nor reduces cold platelet clearance dramatically at 10 min after transfusion. However, the absolute GFP + platelet counts of both FWB and SWB were slightly higher in trauma than in normal controls, suggesting a slightly slower overall platelet clearance in trauma than in controls. The transfusion volume is 20% of estimated total blood volume so that the GFP + positive platelets should be ideally 20% of total platelets after transfusion if there is no clearance. At the end of transfusion, the GFP positive platelets from SWB (in both sham and trauma groups) were 5-7% of total platelets, suggesting that about 50% of transfused SWB platelets cleared during and by the end of transfusion. These results are consistent with the results of radio-labelled recovery and survival studies in humans (Murphy & Gardner, 1969) . The functional benefit of cold stored platelets has been well documented in stored platelet concentrates by reduced platelet storage lesion as compared to platelets stored at room temperature (Reddoch et al, 2014; Bynum et al, 2016) . Recent studies demonstrate that human whole blood stored at 4°C preserves fibrinogen level and platelet response to ADP, thrombin, collagen and arachidonic acid for up to 2 weeks (Pidcoke et al, 2013; Strandenes et al, 2015a) . The results from ex vivo studies in rat blood showed that 7-day refrigerated storage of whole blood modestly reduced the platelet aggregation, had no effect on maximum clot firmness, and shortened the clotting time (Chen et al, 2017) . In this study, the GFP + -platelet counts were approximately 15% and 5% of total platelet populations from FWB and SWB transfusion, respectively, and remained relatively stable within 10 min after transfusion. If bleeding time is around the range of 2-3 min, it suggests that the residual platelets that survived the initial clearance had sufficient time to participate in clot formation when active bleeding occurred, which was supported by immunohistochemistry that showed GFP + -platelets at the clot of the liver incision site under both conditions of sham and ATC. This is consistent with the recent paper showing that platelets derived from cold stored whole blood participate in clot formation at sites of microvascular injury by laser puncture observed by intra-vital microscopy with actual quantification (Torres Filho et al, 2016) . Platelet dysfunction has been demonstrated in ATC (Solomon et al, 2011; Kutcher et al, 2012; Wohlauer et al, 2012) . Studies of clot structure suggest that there may exist a heterogeneity of platelet activation with activated platelets at the core of the clot at the injured endothelium and non-activated platelets at the luminal and clot surface (Chang et al, 2016) , which may explain why the activated platelets derived from SWB could be found in the clot of tissue injury. Clinical studies from combat resuscitation reveal that the patients who receive platelets early in massive transfusion and in higher ratios to packed red blood cells and fresh frozen plasma (FFP) have better outcomes (Holcomb et al, 2011) . Subsequently, this clinical finding and the previous observation that trauma causes platelet dysfunction has been used to justify the concept of "platelet first" transfusion as part of massive transfusion protocols in the Pragmatic Randomised Optimal Platelet and Plasma Ratios (PROPPR) trial (Holcomb et al, 2015; McCurdy et al, 2015) . Therefore, future study is necessary to determine whether the fresh and coldstored platelets participating in clot formation after resuscitation are in relation to their described heterogeneity of function in the circulation and within the core or surface of the clot of injury.
Using cold-stored platelets could raise a potential safety concern based on the possibility of activated cold platelets inducing excess activation of native platelets. In this study, the overall CD62P expression was significantly elevated by SWB transfusion, which is caused by elevated CD62P expression in platelets derived from SWB but not from native platelets, suggesting a minimal impact of SWB on native platelets, which again suggests the safety of using cold-stored whole blood in trauma.
It is still not well clarified whether activated platelets may contribute to multiple organ failure after transfusion. Previous studies suggested that platelets, especially cold-stored platelets, are cleared primarily through hepatocytes, splenic macrophages or directly through adhering to damaged vessel walls, which may be detrimental to organ function or, by contrast, may reduce microvascular bleeding. In this study, we did find GFP + -platelets in multiple organs (liver, lung, spleen and kidney, data not presented here) though without evidence of thrombosis. Furthermore, there is no evidence from our previous study that SWB intensifies acute kidney or lung injury after transfusion in this model (Chen et al, 2017) . A recent study suggests that refrigerated platelets exhibit a greater capacity to inhibit endothelial cell permeability than platelets stored at 22°C (Baimukanova et al, 2016) . This suggests a mechanism for how cold stored platelets could be beneficial in preventing multiple organ failure development after trauma and haemorrhagic shock. Imitation of whole blood with components transfused in the ratio of 1:1:1 (red blood cells (RBC):FFP:platelets) has been shown to have a lower haemostatic capacity than whole blood (Golan et al, 1990; Kornblith et al, 2014) . Whole blood provides balanced blood components with a natural ratio of blood cell and minimally diluted plasma protein and therefore is probably superior to any other resuscitation product to restore blood volume, tissue oxygenation and haemostasis (Spinella et al, 2009; Butler et al, 2014; Strandenes et al, 2015b) . Because of the challenge in procuring FWB, cold-stored whole blood is a viable option, as it is capable of maintaining the haemostatic and platelet function in comparison to room temperature stored whole blood (Jobes et al, 2011; Pidcoke et al, 2013) . In current clinical practice, leucocyte filtration devices that remove most platelets have been recommended for cold-stored whole blood transfusion. However, this study showed that platelets derived from both FWB and SWB functionally contribute to haemostasis in traumatized rats with coagulopathy, suggesting that whole 84 AE 9 # *P < 0Á05, significant difference compared to baseline and posttransfusion; # P < 0Á05, significant difference compared to baseline.
FWB, fresh whole blood; MAP, mean arterial blood pressure; SWB, stored whole blood. The original images of each panel were taken at original magnification 910 with two randomized areas amplified. CD61 was stained in red, GFP was stained in green, and DAPI was stained in blue. DAPI, 4 0 ,6-diamidino-2-phenylindole; FWB, fresh whole blood; GFP, green fluorescence protein; SWB, stored whole blood; T/H, polytrauma and haemorrhage. blood transfusion without leucocyte and platelet filtration may be beneficial for the trauma patient with active bleeding. White blood cells are traditionally considered as a risk factor for febrile non-haemolytic transfusion reactions in whole blood transfusion. We do not have sufficient evidence in this study to clarify the necessity of leucocyte reduction for whole blood transfusion in trauma/haemorrhage. However, it needs to be further justified that the reduction in minor transfusion reactions by leucocyte reduction filters justifies the loss of platelet function in resuscitation of trauma/haemorrhage.
In conclusion, platelets from SWB are in a higher activation state, and have higher clearance rates and platelet-leucocyte aggregates than those in FWB after transfusion in both sham rats and rats with T/H. However, platelets from both fresh and cold-stored whole blood contribute to effective clot formation of tissue injury after transfusion. This study suggests that cold-stored whole blood is an alternative resource to treat trauma patients for potential restoration of haemostatic function. Future study is necessary to optimize the storage of whole blood to prolong the platelet survival rate and optimize haemostatic function.
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